Ep135: John Maraganore on Developing a New Class of Medicines
The Long Run with Luke Timmerman
00:00
Target selection and platform focus
John stresses prioritizing where the technology can make the biggest impact and using genetic validation to reduce risk.
Play episode from 22:55
Transcript
